NVSEF - Novartis AG

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5200.91B
Enterprise Value 3231.23B
Trailing P/E 16.54
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)4.02
Price/Book (mrq)3.91
Enterprise Value/Revenue 34.63
Enterprise Value/EBITDA 613.66

Trading Information

Stock Price History

Beta (5Y Monthly) 0.45
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 398.00
52 Week Low 368.65
50-Day Moving Average 386.78
200-Day Moving Average 387.82

Share Statistics

Avg Vol (3 month) 338.51k
Avg Vol (10 day) 34.66k
Shares Outstanding 52.29B
Float 2.14B
% Held by Insiders 15.77%
% Held by Institutions 132.74%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 43.08
Forward Annual Dividend Yield 43.54%
Trailing Annual Dividend Rate 33.04
Trailing Annual Dividend Yield 33.49%
5 Year Average Dividend Yield 4N/A
Payout Ratio 494.26%
Dividend Date 3Mar. 07, 2018
Ex-Dividend Date 4Mar. 02, 2020
Last Split Factor 240:1
Last Split Date 3May 06, 2001

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Mar. 30, 2020

Profitability

Profit Margin 24.32%
Operating Margin (ttm)24.80%

Management Effectiveness

Return on Assets (ttm)5.93%
Return on Equity (ttm)15.16%

Income Statement

Revenue (ttm)49.93B
Revenue Per Share (ttm)21.90
Quarterly Revenue Growth (yoy)10.90%
Gross Profit (ttm)34.68B
EBITDA 16.92B
Net Income Avi to Common (ttm)7.45B
Diluted EPS (ttm)5.26
Quarterly Earnings Growth (yoy)23.20%

Balance Sheet

Total Cash (mrq)4.76B
Total Cash Per Share (mrq)2.08
Total Debt (mrq)36.69B
Total Debt/Equity (mrq)71.98
Current Ratio (mrq)0.74
Book Value Per Share (mrq)22.24

Cash Flow Statement

Operating Cash Flow (ttm)14.24B
Levered Free Cash Flow (ttm)10.66B